Genistein: Its Role in Breast Cancer Growth and Metastasis

(E-pub Ahead of Print)

Author(s): Vidya Mukund*.

Journal Name: Current Drug Metabolism


Abstract:

Background: The genistein being a phytoestrogen imitates the character of an estrogen which can be useful to treat conditions by reducing the estrogen levels at the time of menopause, osteoporosis and high risk for breast cancer.

Objective: The superior binding of genistein to ERβ might help in reducing breast malignancy risk.

Conclusion: Genistein induces cell cycle arrest, anti-metastatic properties and ultimately affects the breast cancer cell growth by multiple mechanisms. Genistein-mediated anti-proliferative or anti-growth effects are usually observed at higher concentrations. These signaling pathways involve the decrease of NF-κB, HIF-1α, VEGF, and an increase of tumor suppressor p21. This will provide further insight into understanding the biology of transcription factors NF-κB, and HIF-1α in breast cancer.

Keywords: Breast cancer, Genistein, Cell proliferation, Metastasis, Signaling moleculesBreast cancer, Genistein, Cell proliferation, Metastasis, Signaling molecules

Rights & PermissionsPrintExport Cite as


Article Details

(E-pub Ahead of Print)
DOI: 10.2174/1389200221666200120121919
Price: $95

Article Metrics

PDF: 2

Special-new-year-discount